岭南现代临床外科
嶺南現代臨床外科
령남현대림상외과
LINGNAN MODERN CLINICS IN SURGERY
2014年
6期
631-634
,共4页
陈捷%叶义标%罗兴喜%鲁振环%吴潇%陈涛
陳捷%葉義標%囉興喜%魯振環%吳瀟%陳濤
진첩%협의표%라흥희%로진배%오소%진도
腹腔镜%肝切除术%肝血管瘤
腹腔鏡%肝切除術%肝血管瘤
복강경%간절제술%간혈관류
Laparoscopic%Hepatectomy%Hepatic hemangioma
目的:探讨腹腔镜肝切除治疗肝血管瘤的可行性和疗效。方法回顾性分析2011年1月1日至2012年12月31日中山大学孙逸仙纪念医院肝胆外科实施的18例腹腔镜肝切除术治疗肝血管瘤病例的临床资料。结果18例患者均应用腹腔镜完成手术。肝血管瘤平均直径为7.6(5.5~14)cm,手术时间为(121±44)min。13例患者术中选择性半肝阻断,术中平均出血量283(60~900)mL,术后平均住院时间8(6~12)d。术后病理均证实为海绵状血管瘤。术后1例患者并发胸腔积液,经保守治疗痊愈。结论选择合适的病例,掌握半肝血流阻断技术,选择正确的肝实质离断平面,合理应用离断肝实质器械,腹腔镜肝血管瘤手术是安全可行的。
目的:探討腹腔鏡肝切除治療肝血管瘤的可行性和療效。方法迴顧性分析2011年1月1日至2012年12月31日中山大學孫逸仙紀唸醫院肝膽外科實施的18例腹腔鏡肝切除術治療肝血管瘤病例的臨床資料。結果18例患者均應用腹腔鏡完成手術。肝血管瘤平均直徑為7.6(5.5~14)cm,手術時間為(121±44)min。13例患者術中選擇性半肝阻斷,術中平均齣血量283(60~900)mL,術後平均住院時間8(6~12)d。術後病理均證實為海綿狀血管瘤。術後1例患者併髮胸腔積液,經保守治療痊愈。結論選擇閤適的病例,掌握半肝血流阻斷技術,選擇正確的肝實質離斷平麵,閤理應用離斷肝實質器械,腹腔鏡肝血管瘤手術是安全可行的。
목적:탐토복강경간절제치료간혈관류적가행성화료효。방법회고성분석2011년1월1일지2012년12월31일중산대학손일선기념의원간담외과실시적18례복강경간절제술치료간혈관류병례적림상자료。결과18례환자균응용복강경완성수술。간혈관류평균직경위7.6(5.5~14)cm,수술시간위(121±44)min。13례환자술중선택성반간조단,술중평균출혈량283(60~900)mL,술후평균주원시간8(6~12)d。술후병리균증실위해면상혈관류。술후1례환자병발흉강적액,경보수치료전유。결론선택합괄적병례,장악반간혈류조단기술,선택정학적간실질리단평면,합리응용리단간실질기계,복강경간혈관류수술시안전가행적。
Objective To evaluate the feasibility and efficacy of laparoscopic hepatectomy of hepatic hemangioma. Methods Clinical data of 18 patients with hepatic hemangioma who underwent laparoscopic liver resection in Department of Hepatobiliary Surgery , the Sun Yat-sen Memorial Hospital from January 2011 to December 2012 were analyzed retrospectively. Results Laparoscopic hepatectomy of hepatic hemangioma was successfully performed in 18 patients. The mean diameter of hemangioma was 7.6 (5.5-14) cm, the operating time was (121±44) min. Thirteen patients underwent selective inflow controlled, mean blood loss was 283 (60-900) ml, and mean postoperative hospital stay was 8 (6-12)..d. Postoperative pathological examination showed cavernous hemangioma. Postoperative pleural effusion occurred in one patient, and was cured by conservative surgery. Conclusion Laparoscopic hepatectomy of hepatic hemangioma is safe and feasible for selective patients when half-Pringle maneuver and parenchymal transection devices are used appropriately.